(2018). Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis. RMD Open.
Chicago-tyylinen lähdeviittaus"Correction: 4-year Results From the RAPID-PsA Phase 3 Randomised Placebo-controlled Trial of Certolizumab Pegol in Psoriatic Arthritis." RMD Open 2018.
MLA-viite"Correction: 4-year Results From the RAPID-PsA Phase 3 Randomised Placebo-controlled Trial of Certolizumab Pegol in Psoriatic Arthritis." RMD Open 2018.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.